Literature DB >> 20421879

Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive.

Heather Friberg1, Lynne Burns, Marcia Woda, Siripen Kalayanarooj, Timothy P Endy, Henry A F Stephens, Sharone Green, Alan L Rothman, Anuja Mathew.   

Abstract

Cross-reactive memory T cells induced by primary infection with one of the four serotypes of dengue virus (DENV) are hypothesized to have an immunopathological function in secondary heterologous DENV infection. To define the T-cell response to heterologous serotypes, we isolated HLA-A(*)1101-restricted epitope-specific CD8(+) T-cell lines from primary DENV-immune donors. Cell lines exhibited marked cross-reactivity toward peptide variants representing the four DENV serotypes in tetramer binding and functional assays. Many clones responded similarly to homologous and heterologous serotypes with striking cross-reactivity between the DENV-1 and DENV-3 epitope variants. In vitro-stimulated T-cell lines consistently revealed a hierarchical induction of MIP-1β>degranulation>tumor necrosis factor α (TNFα)>interferon-γ (IFNγ), which depended on the concentration of agonistic peptide. Phosphoflow assays showed peptide dose-dependent phosphorylation of ERK1/2, which correlated with cytolysis, degranulation, and induction of TNFα and IFNγ, but not MIP-1β production. This is the first study to show significant DENV serotype-cross-reactivity of CD8(+) T cells after naturally acquired primary infection. We also show qualitatively different T-cell receptor signaling after stimulation with homologous and heterologous peptides. Our data support a model whereby the order of sequential DENV infections influences the immune response to secondary heterologous DENV infection, contributing to varying disease outcomes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421879      PMCID: PMC2929403          DOI: 10.1038/icb.2010.61

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  45 in total

Review 1.  Geographic expansion of dengue: the impact of international travel.

Authors:  Annelies Wilder-Smith; Duane J Gubler
Journal:  Med Clin North Am       Date:  2008-11       Impact factor: 5.456

2.  Multiparameter analysis of intracellular phosphoepitopes in immunophenotyped cell populations by flow cytometry.

Authors:  Omar D Perez; Dennis Mitchell; Roberto Campos; Guo-Jian Gao; Li Li; Garry P Nolan
Journal:  Curr Protoc Cytom       Date:  2005-05

3.  T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?

Authors:  Juthathip Mongkolsapaya; Thaneeya Duangchinda; Wanwisa Dejnirattisai; Sirijit Vasanawathana; Panisadee Avirutnan; Aroonroong Jairungsri; Nuanpan Khemnu; Nattaya Tangthawornchaikul; Pojchong Chotiyarnwong; Kanokwan Sae-Jang; Michael Koch; Yvonne Jones; Andrew McMichael; Xiaoning Xu; Prida Malasit; Gavin Screaton
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

Review 4.  Understanding the contribution of cellular immunity to dengue disease pathogenesis.

Authors:  Anuja Mathew; Alan L Rothman
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

5.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

6.  Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes.

Authors:  Allison Imrie; Janet Meeks; Alexandra Gurary; Munkhzul Sukhbataar; Paul Kitsutani; Paul Effler; Zhengshan Zhao
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

7.  Humidity control as a strategy for lattice optimization applied to crystals of HLA-A*1101 complexed with variant peptides from dengue virus.

Authors:  Pojchong Chotiyarnwong; Guillaume B Stewart-Jones; Michael J Tarry; Wanwisa Dejnirattisai; Christian Siebold; Michael Koch; David I Stuart; Karl Harlos; Prida Malasit; Gavin Screaton; Juthathip Mongkolsapaya; E Yvonne Jones
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-04-06

8.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

9.  Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone.

Authors:  Sarah Rowland-Jones; Tao Dong; Edward Moran; Cameron Simmons; Nguyen Vinh Chau; Kerstin Luhn; Bridget Wills; Nguyen Phuong Dung; Le Thi Thu Thao; Tran Tinh Hien; Jeremy Farrar
Journal:  Eur J Immunol       Date:  2008-04       Impact factor: 5.532

10.  High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection.

Authors:  Tao Dong; Edward Moran; Nguyen Vinh Chau; Cameron Simmons; Kerstin Luhn; Yanchun Peng; Bridget Wills; Nguyen Phuong Dung; Le Thi Thu Thao; Tran Tinh Hien; Andrew McMichael; Jeremy Farrar; Sarah Rowland-Jones
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

View more
  37 in total

1.  The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants.

Authors:  Galina V Petrova; Elena N Naumova; Jack Gorski
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  The necessity and quandaries of dengue vaccine development.

Authors:  Stephen J Thomas
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

Review 3.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

4.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

Review 5.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 6.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

Review 7.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 8.  CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.

Authors:  Laura Rivino; Mei Qiu Lim
Journal:  Immunology       Date:  2016-11-27       Impact factor: 7.397

9.  Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.

Authors:  Daniela Weiskopf; Michael A Angelo; John Sidney; Bjoern Peters; Sujan Shresta; Alessandro Sette
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

10.  Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.

Authors:  Vivian V Costa; Caio T Fagundes; Deborah F Valadão; Thiago V Ávila; Daniel Cisalpino; Rebeca F Rocha; Lucas S Ribeiro; Fernando R Ascenção; Lucas M Kangussu; M Q Celso; Ruiz G Astigarraga; Frederico L Gouveia; Tarcília A Silva; Daniela Bonaventura; Divaldo de Almeida Sampaio; Ana Cristina L Leite; Mauro M Teixeira; Danielle G Souza
Journal:  Med Microbiol Immunol       Date:  2014-04-11       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.